Vyzulta 2,4 mg Eye Drops
PDF Leaflet Revision Date: 22 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.
Dosage (summary)
One drop in the affected eye(s) once daily in the evening.
Onset of Action / Duration
Onset: 1-3 hours, Duration: 11-13 hours
Special Populations
- Paediatric patients
- Elderly patients
Pregnancy & Breastfeeding
Not recommended in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- Concomitant use with other prostaglandin analogues not recommended
Contraindications
- Hypersensitivity to latanoprostene bunod or ingredients
Common side effects
- Conjunctival hyperaemia
- Eye irritation
- Eye pain
Counselling Points
- Do not exceed once daily dosing
- Remove contact lenses before use
Serious warnings
- May cause permanent iris pigmentation
- Caution in intraocular inflammation
Important Disclaimer
The Vyzulta 2,4 mg Eye Drops professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
